Michael A. Narachi
Overview
Michael A. Narachi received an average of $4M in total compensation, including $590K in salary, at Orexigen Therapeutics from 2009 to 2016.
2016Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2015Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2014Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2013Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2012Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2011Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2010Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
2009Orexigen TherapeuticsPresident, Chief Executive Officer and Member of the Board of Directors
Source: SEC filings on May 30, 2017, May 27, 2016, April 22, 2015, April 30, 2014, April 23, 2013, and April 27, 2012.
Related executives
We found 13 more executives who work or worked at Orexigen Therapeutics.
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
Thomas Lynch
Orexigen Therapeutics
General Counsel
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
Heather Turner
Orexigen Therapeutics
General Counsel
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer outgoing
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
Dawn Viveash
Orexigen Therapeutics